DK0584136T3 - Bestemmelse af peptidmotiver på MHC-molekyler - Google Patents

Bestemmelse af peptidmotiver på MHC-molekyler

Info

Publication number
DK0584136T3
DK0584136T3 DK92909723T DK92909723T DK0584136T3 DK 0584136 T3 DK0584136 T3 DK 0584136T3 DK 92909723 T DK92909723 T DK 92909723T DK 92909723 T DK92909723 T DK 92909723T DK 0584136 T3 DK0584136 T3 DK 0584136T3
Authority
DK
Denmark
Prior art keywords
peptide motifs
pct
determination
date
mhc molecules
Prior art date
Application number
DK92909723T
Other languages
Danish (da)
English (en)
Inventor
Olaf Ritzschke
Stefan Stevanovic
Hans-Georg Rammensee
Kirsten Falk
Guenther Jung
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19914116256 external-priority patent/DE4116256C2/de
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK0584136T3 publication Critical patent/DK0584136T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK92909723T 1991-05-17 1992-05-15 Bestemmelse af peptidmotiver på MHC-molekyler DK0584136T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19914116256 DE4116256C2 (de) 1991-05-17 1991-05-17 Bestimmung von Peptidmotiven auf MHC-Molekülen
PCT/EP1992/001072 WO1992021033A1 (fr) 1991-05-17 1992-05-15 Determination de motifs de peptides sur des molecules du complexe majeur d'histocompatibilite

Publications (1)

Publication Number Publication Date
DK0584136T3 true DK0584136T3 (da) 2000-05-22

Family

ID=6431930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909723T DK0584136T3 (da) 1991-05-17 1992-05-15 Bestemmelse af peptidmotiver på MHC-molekyler

Country Status (10)

Country Link
US (1) US5747269A (fr)
EP (1) EP0584136B1 (fr)
JP (2) JP3424752B2 (fr)
AT (1) ATE189527T1 (fr)
AU (1) AU1694392A (fr)
CA (2) CA2471093A1 (fr)
DE (2) DE4143467C2 (fr)
DK (1) DK0584136T3 (fr)
ES (1) ES2145007T3 (fr)
WO (1) WO1992021033A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252829B1 (en) 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
AU4998993A (en) * 1992-08-07 1994-03-03 Epimmune, Inc. Hla binding peptides and their uses
US9340577B2 (en) 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
DE4238416A1 (de) * 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen
DE4423392A1 (de) * 1994-07-04 1996-01-11 Birsner & Grob Biotech Gmbh Verfahren zur Identifizierung antigener Peptide
US6413517B1 (en) 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
US6977074B2 (en) * 1997-07-10 2005-12-20 Mannkind Corporation Method of inducing a CTL response
US6994851B1 (en) 1997-07-10 2006-02-07 Mannkind Corporation Method of inducing a CTL response
US20030138808A1 (en) * 1998-02-19 2003-07-24 Simard John J.L. Expression vectors encoding epitopes of target-associated antigens
US6379970B1 (en) * 1999-04-30 2002-04-30 The Arizona Board Of Regents On Behalf Of The University Of Arizona Analysis of differential protein expression
DE19925235A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925199A1 (de) * 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
CA2377525A1 (fr) * 1999-07-19 2001-03-29 Epimmune, Inc. Induction de reponses immunitaires cellulaires au virus de l'hepatite c mettant en oeuvre des compositions de peptides et d'acide nucleique
ATE445643T1 (de) 1999-11-18 2009-10-15 Pharmexa Inc Heteroklitische analoga von klasse-i epitopen
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
EP2248910A1 (fr) * 2000-04-28 2010-11-10 Mannkind Corporation Synchronisation d'épitopes dans les cellules présentatrice d'antigène
US20030215425A1 (en) * 2001-12-07 2003-11-20 Simard John J. L. Epitope synchronization in antigen presenting cells
US6861234B1 (en) 2000-04-28 2005-03-01 Mannkind Corporation Method of epitope discovery
US7919467B2 (en) * 2000-12-04 2011-04-05 Immunotope, Inc. Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
DE60238864D1 (de) * 2001-11-07 2011-02-17 Mankind Corp Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption
US20050221350A1 (en) * 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
US9090673B2 (en) 2003-12-12 2015-07-28 City Of Hope Synthetic conjugate of CpG DNA and T-help/CTL peptide
AU2005321940B2 (en) * 2004-12-29 2012-04-19 Mannkind Corporation Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
US7756644B2 (en) * 2005-05-12 2010-07-13 Merck & Co., Inc. System and method for automated selection of T-cell epitopes
CA2609038A1 (fr) 2005-05-18 2006-11-23 Trinity Biosystems, Inc. Procedes et compositions permettant l'immunisation contre les infections a chlamydia
US20070248628A1 (en) * 2005-12-06 2007-10-25 Keller Lorraine H Immunogens in cancer stem cells
US20080107668A1 (en) * 2006-08-30 2008-05-08 Immunotope, Inc. Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
EP2129389B1 (fr) 2007-02-15 2014-10-08 MannKind Corporation Procede d'amelioration de la reponse des cellules t
EP2152890A1 (fr) * 2007-05-23 2010-02-17 MannKind Corporation Vecteurs multicistroniques et procédés pour leur conception
WO2010086294A2 (fr) 2009-01-28 2010-08-05 Epimmune Inc. Polypeptides de liaison de pan-dr et leurs utilisations
EP2490713A2 (fr) 2009-10-23 2012-08-29 MannKind Corporation Immunothérapie pour le cancer et procédé de traitement du cancer
MA42420A (fr) 2015-05-13 2018-05-23 Agenus Inc Vaccins pour le traitement et la prévention du cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619458B2 (en) * 1987-01-30 1992-01-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte inhibition by hla peptides
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases

Also Published As

Publication number Publication date
EP0584136B1 (fr) 2000-02-02
CA2103148C (fr) 2004-07-20
DE4143467C2 (de) 1995-02-09
ES2145007T3 (es) 2000-07-01
US5747269A (en) 1998-05-05
JP2003176300A (ja) 2003-06-24
ATE189527T1 (de) 2000-02-15
JP3424752B2 (ja) 2003-07-07
JPH06510850A (ja) 1994-12-01
CA2103148A1 (fr) 1992-11-18
AU1694392A (en) 1992-12-30
DE59209810D1 (de) 2000-03-09
CA2471093A1 (fr) 1992-11-26
EP0584136A1 (fr) 1994-03-02
WO1992021033A1 (fr) 1992-11-26

Similar Documents

Publication Publication Date Title
DK0584136T3 (da) Bestemmelse af peptidmotiver på MHC-molekyler
DK0696297T3 (da) Pyridobisimidazolbaseret stiv stavpolymer
DK0669001T3 (da) Bestemmelse af peptidmotiver på MHC-molekyler
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DK0912176T3 (da) Anvendelse af pyridylalkan-, pyridylalken- og/eller pyridylalkynsyreamider til behandling af tumorer eller immunosuppression
TR200200068T2 (tr) Nematisital triflüorobütenler
ATE166650T1 (de) Spiroazacyclischderivate als substanz p antagonisten
DE59204623D1 (de) Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse.
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
NO934680L (no) Herdbare organopolysiloksanmasser
ES2053907T3 (es) Pomada topica.
DE69225410D1 (de) Herstellung von n-acetylneuraminsäure-derivaten
HUT77631A (hu) Eljárás a levobupivakain és származékai rezolválására
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
ATE128714T1 (de) Erythromycinderivate.
ATE169019T1 (de) Xanthinderivate als adenosin-a1 rezeptor antagonisten
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
DE69323191D1 (de) Wasserlösliche retinoide
ES2123570T3 (es) Uso de la molecula de adhesion de leucocitos y endotelios 1 y anticuerpos contra ella en el tratamiento del asma.
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
FI875379A0 (fi) Koostumuksia käytettäviksi tomodensitometriassa
DK0958290T3 (da) 1,4-Dihydropyridinderivater og terapeutisk anvendelse heraf
NO974687D0 (no) Kondenserte <beta>-carboliner
SE9501773D0 (sv) New use